..................................................
I will delete posts that are
solicitation from a pump site
or solicitation of us by salesmen
..................................................
$NEXCF at resistance $0.88
OTC/QB avg daily volume (low) 16k website hold x 100% sell filings and news 3/27/2020
$6 million in Revenues Period Ended December 31st 2019
$SHMP looking for a bottom $0.027
OTC/QB - made a ton of money the 1st run ($0.02)
Avg daily Volume 440k
Now looking for a bottom play re entry. A Game Changer stock.
Perfected clean "farming" of salt water shrimp and fish. Website float 300.64m
100% sell filings and news 3/18/20 a fire has destroyed the main building
Note:
We are adopting a policy
of barring and deleting paid humps and the like !!
I will delete any paid promo. They come here to make
some use of our casual stock sharing environment.
Good riddance.
Sign in the entrance window:
We will also delete any so-called market research
advertisement or any post fronting such off-site and
any off-site email sign-up or company solicitation.
< All foreign exchange stocks are welcome so long
as their exchange is clearly shown each posting.
A word to the wise:
"Stock picking is work".
"The stock market
is all about work."
"Just you and it "
We follow stocks with a low float < 100M
and stocks with an ultra low float < 30M.
But whatever is moving well, makes a1list.
Charts qualify that are looking up in some way:
on a moving average at resistance or support,
or with a staging formation such as a bull flag.
An upgrading Pr is great too.
The float shown is the highest number
from OTCMarkets-YahooFinance-WSJournal.
I use the highest of any two I look at.
Re: O/S Checked against SEC filings.
The Art of Choosing the Right Dumpster When you're up against a home cleanout or remodel, the dumpster's a hero you didn't know you needed. For folks in Roseburg, Oregon, this comes down to the savvy words of Dori John, a waste management expert who's got the lowdown on dumpster decision-making. Think you can just guess how big a container you need by eyeballing your...
AI's Growing Footprint in Global Strategies Let's get straight to it: AI's not just playing in the background anymore—it's front and center, dipping its fingers into everything from budget spreadsheets to boardroom agendas. Infotech's annual Tech Trends 2027 report isn't mincing words about AI either, spotlighting 14 trends across four themes that tech leaders better be...
Riding the Aging Wave in Columbus The Perfect Companion is no stranger to the ups and downs of the eldercare industry. Celebrating five years in Columbus, this eldercare outfit's trying to pull off what many can't—a solid expansion in a landscape where finding reliable home care employees is about as easy as pulling teeth. But here they are, aiming to hire 25 more...
A Major Step Forward in AI Infrastructure When two heavyweights clash, you better believe folks are paying attention. OneQode’s deal with AdaniConneX is like a shot across the bow in the AI infrastructure arena. They’re not just dipping a toe in India’s tech waters; they’re diving headfirst with 14 MW of data center muscle right there in Siruseri Sipcot, Chennai....
China's Capital Markets: A New Era Dawns Guosen Securities is ringing the bell for a fundamental shift in China's capital markets, folks. As we're about to roll into the 15th Five-Year Plan period, they're not just talking about expansion anymore. Nope, it's all about reshaping the landscape with regulatory reforms, innovation, and international integration. If you think...
Beta Bionics Takes a Hit: What's Behind the Drop? You ever have one of those moments where you wonder if you missed a memo? Well, folks investing in Beta Bionics (NASDAQ:BBNX) sure might feel that way after a staggering 37% plunge in their stock. The issue here isn't just the drop—it's what spurred it: a securities class action lawsuit alleging some murky disclosures...
Wading into the murky waters of U.S. healthcare insurance isn't for the faint of heart, but Altea's making its move. Backed by MISSION, they're banking on a niche strategy by tapping veteran Justin Rodrick as Vice President. Their tactic? Aim squarely at the under-served segment of small to mid-sized medical and healthcare facilities. The play's bold, and if Rodrick's got...
Shifting Gears: Patriot Growth's New Leadership Turn When it comes to tightening the ship and pointing towards uncharted waters, new leadership can be the key. This couldn't be more true for Patriot Growth Insurance Services as they welcome Rajeev Jain aboard as their latest Chief Operating Officer. This move is all about reinforcing their commitment to operational...
Bracco's Bold Move into U.S. Manufacturing In the bustling world of diagnostic imaging, Bracco's latest announcement is like a welcome jolt. They're shelling out $230 million for a new manufacturing facility in Sanford, North Carolina. If you've been around the block in this sector, this move screams ambition—Bracco's playing the long game here. Strategic Location: A...
The Surge in Popularity of Manual Lymphatic Massage There's a whole lotta buzz around manual lymphatic drainage (MLD) these days, and folks want to know if all that hype's got any juice. During National Massage Therapy Awareness Week, the American Massage Therapy Association (AMTA) lent a hand by spotlighting what the latest research has to say about this specialized...
CompTIA's Upcoming Session at TechNet Augusta Conference CompTIA is set to present a significant session at the upcoming TechNet Augusta conference, focusing on how people, data, and artificial intelligence (AI) can come together to enhance the readiness of cybersecurity. This session is an integral part of the CompTIA Learning Solutions Series, scheduled for a day...
Laura Mercier Launches on Amazon Premium Beauty Award-winning beauty brand Laura Mercier has officially launched on the Amazon U.S. Premium Beauty Store, enhancing accessibility to high-quality beauty products. Renowned for its artistry-inspired makeup and skincare lines, Laura Mercier is now joining forces with Amazon, making it easier for beauty enthusiasts everywhere...
Truist Adjusts Merck's Price Target Recently, Truist Securities revised its price target for Merck & Co., Inc. (NYSE:MRK) from $143.00 down to $132.00. Despite this adjustment, they continue to maintain a Buy rating for the stock, showcasing their confidence in its long-term potential. Impact of the Recent Acquisition This downgrade comes on the heels of Merck's...
Xilio Therapeutics Expands Team with Stock Options Grant Xilio Therapeutics, Inc. (Nasdaq: XLO), a cutting-edge biotechnology firm focused on developing tumor-activated immuno-oncology therapies, is making significant strides in its mission to support those living with cancer. In an exciting development, the company has announced the granting of a non-qualified stock...
For the analytical investor, every property acquisition begins with the numbers. In Portugal, a market celebrated for its steady growth and robust financial incentives, understanding mortgage dynamics is essential to making sound investment decisions. You might find that a deep dive into Portugal’s mortgage landscape reveals both challenges and substantial...